Literature DB >> 509835

Radiology of seronegative spondyloarthropathies.

D Resnick.   

Abstract

Radiographic manifestations of the seronegative spondyloarthropathies superficially resemble the findings of rheumatoid arthritis although they differ in both distribution and pattern of disease. Ankylosing spondylitis has a predilection for the axial skeleton; psoriatic arthritis may involve distal interphalangeal joints; and Reiter's syndrome is most commonly associated with asymmetrical lower extremity alterations. The absence of osteoporosis and the presence of bony proliferation are also noted in these disorders. Sacroiliitis and spondylitis, which can be observed in any of these disease, may have distinctive features. In ankylosing spondylitis, bilateral saroiliac joint alterations and typical syndesmophytes are common; in Reiter's syndrome and psoriasis, asymmetrical saroiliac joint changes and bulky spinal outgrowths may be observed. The physician should be aware of typical roentgen findings in each of the spondyloarthropathies.

Entities:  

Mesh:

Year:  1979        PMID: 509835

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Established criteria for disease controlling drugs in ankylosing spondylitis.

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis.

Authors:  B J Harrison; C E Hutchinson; J Adams; I N Bruce; A L Herrick
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

3.  Progressive ankylosis (ank/ank) in mice: an animal model of spondyloarthropathy. III. Proliferative spleen cell response to T cell mitogens.

Authors:  H E Krug; M L Mahowald; C Clark
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 4.  MRI in psoriatic arthritis: insights into pathogenesis and treatment response.

Authors:  Fiona M McQueen; Nicola Dalbeth; Anthony Doyle
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.